Skip to main content
Equibles

FMR LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 315066 BOSTON, MA
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,235,405
+$2,740,314 QoQ
Shares Held
776,462
-2.7% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. DSGN ranks #156 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in DSGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,235,405 776,462
2026-03-31 $8,495,091 798,411
2025-12-31 $7,234,493 771,268
2025-09-30 $5,578,592 740,849
2025-06-30 $3,205,537 951,198
2025-03-31 $3,659,472 948,050
2024-12-31 $5,873,111 951,882
2024-09-30 $4,458,217 828,665
2024-06-30 $271,403 81,016
2024-03-31 $315,714 78,341
2023-12-31 $209,381 79,012
2023-09-30 $165,336 70,058
2023-06-30 $4,017,951 637,770
2023-03-31 $5,527,100 957,903
2022-12-31 $11,486,449 1,119,537
2022-09-30 $18,105,452 1,082,862
2022-06-30 $14,377,160 1,026,940
2022-03-31 $16,591,960 1,027,366
2021-12-31 $21,410,000 1,000,000
2021-09-30 $14,690,000 1,000,000
2021-06-30 $19,890,000 1,000,000
2021-03-31 $29,900,000 1,000,000